{
    "code": "02016646",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02016646",
    "time": "2016-11-18 19:11:07",
    "許可證字號": "衛署藥輸字第016646號",
    "註銷狀態": "已註銷",
    "註銷日期": "94\/06\/15",
    "註銷理由": "未展延而逾期者",
    "有效日期": "87\/06\/09",
    "發證日期": "77\/06\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201664602",
    "中文品名": "格利奧斯汀注射液",
    "英文品名": "GULLIOSTIN INJECTION",
    "適應症": "對於慢性狹心症之治療可能有效",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DIPYRIDAMOLE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0926501100  政泰實業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260321000  TAIYO PHARMACEUTICAL INDUSTRY CO. LTD.",
        "製造廠廠址": "1040-22 MATSUNOKI-CHO, TAKAYAMA CITY, GIFU PREFECTUREJAPAN.3-24-2 AOI, HIGASHI-KU, NAGOYA CITY JAPAN",
        "製造廠公司地址": "3-24-2 AOI, HIGASHI-KU, NAGOYA CITY JAPAN",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412400400",
            "成分名稱": "DIPYRIDAMOLE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ]
}